INDEPTH Network Effectiveness and Safety Studies Platform (INESS) Update-INDEPTH AGM 2010 Aziza Mwisongo INESS secretariat Sep, 2010.

Slides:



Advertisements
Similar presentations
New Challenges in M&E Lets go. Scaling Up Monitoring & Evaluation Strategic Information PROGRAM GUIDANCE RESULT NEEDS OPPORTUNITIES Resources New directions.
Advertisements

Follow-up after training and supportive supervision The IMAI District Coordinator Course.
Celebrating Achievements
Referral of participants for HIV follow-up care Africa Centre MDP experiences Presented by: Hlengiwe Ndlovu MDP Clinic coordinator.
Private Sector Malaria Case Management: Experience from 7 years of implementation in Cambodia Presented by Dr. Socheat, Director of CNM RBM Working Group.
National Human Resources for Health Observatory HRH Research Forum Dr. Ayat Abuagla.
Malaria Elimination in Zanzibar. Introduction Dramatic declines in malaria morbidity and mortality over the last decade (prevalence remained
APPMG World Malaria Day Event, 2013 Invest in The Future: Defeat Malaria Kolawole Maxwell, Malaria Consortium Nigeria Country Director.
Project HEART Transition Monitoring Challenges and Successes of Monitoring Health System Capacity August 12, 2010 Rozalin Wise.
Development of a tool for assessing site-readiness for the provision of vaginal microbicides and oral PrEP in South Africa.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
PARIS 21 Meeting Ghana July Challenges in health information Health Metrics Network HMN Framework and profiling tool.
Comprehensive M&E Systems
Country report-Tanzania Presented to EARN Annual Malaria Conference Kigali, Rwanda 15th –19 th November, 2004 NMCP.
World Health Organization
1 Module 6 Putting It All Together. 2 Learning Objectives At the end of this session participants will understand: The monitoring and evaluation process.
EDM STRATEGY FOR WORKING WITH COUNTRIES-TANZANIA Rose Shija EDM NPO TANZANIA.
TANZANIA PROGRESS R A Khatib, B Amuri, M Alexander, Y Mkilindi, S Abdulla.
8/29/20151 POPULATION STUDIES AND RESEARCH INSTITUTE (PSRI) UNIVERSITY OF NAIROBI, KENYA RUSINGA DSS ON THURSDAY 12 TH MARCH 2015.
Importance of Health Information Systems Information explosion during 1990s  It is estimated that in the next 50 years, the amount of knowledge currently.
Access to health care, social protection, and household costs of illness proposal Cost of illness working group INDEPTH AGM 2009, Pune.
HIV research in the era of ART: changing priorities in Tanzania Basia Zaba SOAS 3 rd March 2011.
HIV Patient ART Monitoring Meeting: International Conference Centre, Geneva March 2004 Defining the variables.
Roll Back Malaria Monitoring & Evaluation Reference Group (MERG) RBM 12 th Partnership Board Meeting Geneva, May 10-11, 2007 Bernard Nahlen Bernard Nahlen.
INDEPTH Network Effectiveness and Safety Studies Platform (INESS) Introduction to Systems Effectiveness Modules Don de Savigny INDEPTH Scientific Advisory.
Overview Burkina--- ART Population: 11 millions Prevalence: 6.6% (surveillance data) Estimate of 650,000 PLWHA 300 peoples with red cross 2000 people to.
INDEPTH NETWORK – UPDATE & CURRENT CHALLENGES SEACO, November 2011, Johor, Ruth Bonita (acknowledgements to David Ross, Chair INDEPTH SAC)
Pharmacovigilance of antimalarial drugs in Uganda Hasifa Bukirwa Uganda Malaria Surveillance Project Funded by: CDC/PMI and EDCTP.
FHI’s Global ART Program: Today's snapshot and tomorrow's vision 10 August 2010 Kwasi Torpey, MD, PhD, MPH Regional Senior Technical Advisor, FHI 8 th.
INDEPTH Effectiveness and Safety studies of antimalarials in Africa (INESS ) IMPLEMENTATION SO FAR Aziza Mwisongo INDEPTH AGM PUNE, INDIA October 2009.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
6 th Biannual Joint HIV Sector Review Meeting Nov 11-13,2014 Ministry of Health and Social Welfare Mwanaisha Nyamkara, NTLP Werner Maokola, NACP Nov 11,
Malaria Case management KPA conference. Presentation outline  Introduction  National malaria strategy  Case management targets  AMFm subsidy  The.
Nabaggala Ruth Monitoring and Evaluation Officer UPMB 21 September
Malaria treatment policies: the challenge, strategies and the options SOTA, Nairobi, Kenya 12 th June 2002.
Omondi Robert Sadia University of Nairobi
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
ANC surveillance research Yusufu Kumogola, Emma Slaymaker, Raphael Isingo, Julius Mngara, Basia Zaba, John Changalucha and Mark Urassa TAZAMA / NACP seminar,
Epilepsy and WHO | 17 Oct |1 | WHO's six-point agenda The overarching health needs 1.Promoting development 2.Fostering health security The strategic.
HIV and AIDS Epidemic: Potential Contribution from DSS sites Nyovani Madise, PhD Centre for Global Health, Population, Poverty & Policy.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
Assuring Safety for Clinical Techniques and Procedures MODULE 5 Facilitative Supervision for Quality Improvement Curriculum 2008.
Experiences in Tanzania: Community Based Efforts to Support HIV/TB Integration Jackson Mugyabuso Dr. Charlotte Colvin PATH 25 July 2012.
A BASELINE SURVEY OF THE PHARMACEUTICAL SECTOR IN TANZANIA
Livesy Abokyi Kintampo Health Research Centre 9 th INDEPTH AGM th October,2009 Pune, INDIA.
1 Policy and programme lessons from the Multi-Country Evaluation (MCE) of IMCI The MCE Team.
Group B Comparison of the different types of programs.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Kenya Roadmap to Achieve RBM Targets September 2009 – December 2010.
MDGs 4 and 5: What Can HDSS sites contribute? Don de Savigny INDEPTH Scientific Advisory Committee.
INDEPTH Network Better Health Information for Better Health Policy Work Plan 2009 Associated Budget 2009 Secretariat Presentation to the Board Finalised.
HIV TESTING AND EXPANSION OF ART FOR TB PATIENTS, BOTTLE NECKS CHALLENGES AND ENABLERS FOR SCALE UP IN KENYA DR. JOSEPH SITIENEI, OGW NTP MANAGER - KENYA.
Medical Certification on Cause of Death Session V: Verbal Autopsy.
Effective HIV & SRH Responses among Key Populations Module 3: Engaging Key Populations with HIV and SRH Services.
MONITORING THE PHARMACEUTICAL SECTOR IN A DEVELOPING COUNTRY - THE GHANA EXAMPLE Gyansa-Lutterodt M. 1,7, Andrews E 2, Arhinful D 3,7, Addo-Atuah J 4,7,
Overview of National Center for Health Statistics (NCHS) Data Systems Mary Burgess
Learning About Drug Use1 An Overview of the Process of Changing Drug Use 1. EXAMINE Measure Existing Practices (Descriptive Quantitative Studies) 2. DIAGNOSE.
Annual Operational Plan 5 Mid-term (July – December 2009) Progress report Dr S K Sharif Director Public Health & Sanitation.
Jaran Eriksen MD, PhD Student International Health (IHCAR) & Clinical Pharmacology Karolinska Institute, Stockholm, Sweden.
Assessing Logistics System Supply Chain Management 1.
Definition of indicators Facilitators’ Workshop on District Health Performance Improvement Lilongwe, 25 th – 27 th March 2015.
National TB Infection Control Seminar S’celo S. Dlamini Director: Research, Information, Monitoring, Evaluation & Surveillance 12 th of August 2015 Integrating.
Honorati Masanja, Henry Mwanyika, William Kafura & Don de Savigny Rufiji Sentinel Surveillance System Ifakara Health Research & Development Center Swiss.
Module 8 Guidelines for evaluating the SDGs through an equity focused and gender responsive lens: Overview Technical Assistance on Evaluating SDGs: Leave.
11 viii. Develop capacity for signal detection and causality assessment Multi-partner training package on active TB drug safety monitoring and management.
Malaria Programmes and Implication on Strengthening the overall Health System Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines.
TRACE INITIATIVE: Data Use
Dan Kajungu, PhD, Collins Gyezaho, Davis Natukwatsa.
Illustrative Cluster Detection and Response Strategy
Root Cause Analysis Identifying critical campaign challenges and diagnosing bottlenecks.
Presentation transcript:

INDEPTH Network Effectiveness and Safety Studies Platform (INESS) Update-INDEPTH AGM 2010 Aziza Mwisongo INESS secretariat Sep, 2010

INESS objectives  To develop and maintain a phase IV Effectiveness and safety studies platform.  To assess the effectiveness, and determinants of effectiveness, of new malaria treatments in real world health systems. m in antimalarials in Africa  To evaluate safety of new treatments through a comprehensive pharmacovigilance in a health system context

Challenge for INDEPTH HDSS  To move beyond population health observatories to include a health system observatory function  To link population health and health behaviours to health services and to health system behaviours

= 37% 98% Driving with the brakes on: How interventions lose traction in health systems Example of ACT anti-malarial treatment in Rufiji DSS in 2006 Efficacy X Access X Diagnostics X Provider compliance X Patient adherence Effectiveness X 95% X 70% X 60% Health system factors Averages mask inequities X 40% X 90% X 75% X 60% = 16% Poorest quintile Data source: IMPACT Tanzania. Effectiveness data are actual. Poorest quintile estimates are hypothetical

What does this mean?  Presently more traction can be gained by removing health system bottlenecks than by improving the efficacy of new drugs.

INESS Technical approach for systems effectiveness  So seven linked study modules for the effectiveness estimation: ModuleTask team facilitator 1AccessSTI 2Diagnostic targetingCDC 3Provider complianceCDC 4Patient AdherenceSTI 5Community acceptabilityCDC 6Contexts and other effectsSTI 7Costs and cost effectivenessSPH Level HH HF HH Community & HF District & HH District, HF & HH

Other supportive modules of INESS  Safety Monitoring  Data Linkage  Data analysis and synthesis

Module 1. Access  Main purpose:  determine proportion of cases needing to seek care that actually gain physical access to a point of provision Quick overview and update :  Ongoing Household surveys of fevers in prior two weeks through HDSS rounds  Will provide total annual fever burden  Plans to analyze across time, space, socio-economic quintiles and provider characteristics

Module 2 & 3. Diagnostic targeting & Provider compliance  Main purpose:  determine the proportion of cases having access that are correctly diagnosed / classified  determine the proportion of correctly diagnosed cases that are provided with the correct treatment Quick overview and update:  On going Health facility / provider surveys  Sampled at peak and low seasons –all sites collected one season data  Exit interviews with gold standard diagnostic  Assesses stock-outs and quality of drugs on hand

Module 4. Patient adherence  Main purpose:  Estimate proportion of patients who receive treatment who use it as intended; and the proportion who are satisfied with the treatment Quick overview and update:  Household survey ongoing  Standard interviews for adherence and acceptability  Further follow-up and filter paper blood at day 28 (and 42 depending on ACT)  RDT taken

Module 5. Community acceptance  Main purpose:  Examine the social, cultural and behavioural factors that facilitate or impede uptake and adherence to new ACTs when introduced Quick overview and update:  Community survey of three different populations  Persons having a recent malaria fever episode (45-50 interviews)  Adult men & women living in DSS area (15 FGDs per year)  ACT providers (15-20 interviews)  Two communities 5km from ACT

Module 6. Contexts and additional effects  Main purpose:  Estimate the contribution to reduced morbidity & mortality. Quick overview and update  Training on the module has been concluded in August 2010  HMIS document reviews for trends and patterns in:  DSS database and VA review for trends in:  Other contextual data (rainfall, EIR, molecular markers for resistance)  Plans to repeat therapeutic efficacy (100 patients)

Module 7. Overall effectiveness and costs  Main purpose:  Determine the effectiveness, and the determinants of effectiveness Quick overview and update:  Plan to put it all together  Determine overall population effectiveness by equity quintile  Determine the efficacy losses, and where the greatest losses occur

Safety Monitoring module  Main purpose:  To strengthen existing safety monitoring system and to collect longitudinal data on safety of ACTs Quick overview and update Spontaneous adverse event reporting system strengthened Active cohort event monitoring ongoing Plans to link Health Information & Demographic Surveillance Systems INESS – a platform to generate data on safety in pregnancy

Policy analysis module  Main purpose: To learn and understand processes and dynamics involved with formulation and implementation of antimalarial policies at international, national and district level Quick overview and update  Module SOPS and tools developed  Stakeholder analysis of all actors concerned with the policy change; national & sentinel DSS district  Documentation of national procurement & supply chain (to sentinel district)  Document analysis of Rx guidelines

Data linkage module  Main purpose Provide a mechanism to identify HDSS residents visiting HF and link their information Quick overview and update  INESS data linkage softwares developed and applied  Biometric enrolment is ongoing in the HDSS  Piloting of the system in health facilities is ongoing  To fully operationalise the data linkage system to link data sets

Thank you